Roche Holding Ltd. logo

Roche Holding Ltd. (ROCH)

Market Closed
12 Jun, 20:00
NEO-L NEO-L
CA$
12. 30
+0.39
+3.2746%
CA$
456.96B Market Cap
17.54 P/E Ratio
- Div Yield
2,882 Volume
0 Eps
CA$ 11.91
Previous Close
Add Transaction
Day Range
12.21 12.3
Year Range
8.96 14
Want to track ROCH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ROCH closed today higher at CA$12.3, an increase of 3.2746% from yesterday's close, completing a monthly increase of 0.7371% or CA$0.09. Over the past 12 months, ROCH stock gained 1.6529%.
ROCH is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

ROCH Chart

People also search for

AbbVie Inc. CDR
CA$ 31.7
+0.5711%
ROG
Roche Holding AG
CA$ 25.64
0%
NVS
Novartis AG
CA$ 29.11
+3.705%
Gilead Sciences Inc. CDR
CA$ 25.42
-0.6643%

Roche Holding Ltd. (ROCH) FAQ

What is the stock price today?

The current price is CA$12.30.

On which exchange is it traded?

Roche Holding Ltd. is listed on NEO-L.

What is its stock symbol?

The ticker symbol is ROCH.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 456.96B.

Has Roche Holding Ltd. ever had a stock split?

No, there has never been a stock split.

Roche Holding Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Thomas Schinecker CEO
NEO-L Exchange
- ISIN
CH Country
103,249 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Roche Holding AG is a global leader in healthcare, with a strong focus on pharmaceuticals and diagnostics. The company has a presence across Europe, North America, Latin America, Asia, Africa, Australia, and Oceania, showcasing a truly international footprint. Founded in 1896, Roche has a long-standing history of innovation and dedication to improving health outcomes. Based in Basel, Switzerland, this esteemed company has been at the forefront of developing and providing solutions to some of the most pressing health challenges faced around the world.

Products and Services

Roche Holding AG offers a broad portfolio of products and services, catering to a wide range of therapeutic areas and diagnostic needs:

  • Pharmaceutical Products

    These include a variety of medications aimed at treating conditions in therapeutic areas such as anemia, various types of blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune diseases, neurological disorders, ophthalmology, respiratory disorders, and transplantation. Roche is also actively developing new pharmaceutical products to address unmet medical needs in these and other areas.

  • In Vitro Diagnostic Tests

    Roche provides a comprehensive range of diagnostic tests for the detection of diseases like cancer, diabetes, Covid-19, hepatitis, human papillomavirus (HPV), among others. These diagnostic tools are essential in the early detection, diagnosis, and monitoring of diseases, leading to better patient outcomes.

  • Diagnostic Instruments

    The company also offers advanced diagnostic instruments used by laboratories, hospitals, and healthcare providers globally. These instruments are crucial for conducting the in vitro diagnostic tests, ensuring accuracy and efficiency in diagnostics.

  • Digital Health Solutions

    Understanding the increasing role of technology in healthcare, Roche is also involved in offering digital health solutions. These innovative technologies aim to improve patient care, enhance diagnostic and therapeutic processes, and enable healthcare providers to deliver more personalized and efficient care.

Contact Information

Address: Konzern Hauptsitz
Phone: 41 61 688 11 11